Endurance Wealth Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
Other funds holding ISEE
ACA
UOC
BCM
TAL
Endurance Wealth Management's ISEE Position: Q2 2023 in Review
Endurance Wealth Management reduced its IVERIC bio, Inc. Common Stock (ISEE) stake by 44% in Q2 2023, selling an estimated $42.4K and leaving 1,500 shares worth $59K. The position accounts for 0.01% of the portfolio, ranked #319.
Endurance Wealth Management first reported a position in ISEE in Q2 2015 and has held it in 33 quarters since. The position peaked at $79K in Q4 2015. 255 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.
- Endurance Wealth Management held 1,500 shares of IVERIC bio, Inc. Common Stock worth $59K as of Q2 2023.
- Endurance Wealth Management sold 1,200 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $42.4K.
- IVERIC bio, Inc. Common Stock made up 0.01% of Endurance Wealth Management's portfolio in Q2 2023, its #319 holding.
- Endurance Wealth Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2015 and has held it in 33 quarters since.
- Endurance Wealth Management's IVERIC bio, Inc. Common Stock position peaked at $79K in Q4 2015.
- 255 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.
Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.